Ray Hachem

12.7k citations

218 papers · 8.9k indexed · h-index 53

Impact in

Infectious Diseases top 0.1%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
Emergency Medical Services top 0.05%
- Central Venous Catheters and Hemodialysis

Papers in

Emergency Medical Services 62
- Central Venous Catheters and Hemodialysis 62
Clinical Biochemistry 45
- Bacterial Identification and Susceptibility Testing 45

Co-authors: Issam Raad Hend Hanna Dimitrios P. Kontoyiannis Ying Jiang Gerald P. Bodey Maha Boktour Tanya Dvorak Roy F. Chemaly
Journals: Antimicrobial Agents and Chemotherapy (29 papers)Cancer (22 papers)Open Forum Infectious Diseases (21 papers)Clinical Infectious Diseases (18 papers)Infection Control and Hospital Epidemiology (16 papers)
Partner nations: United States Lebanon Japan

In The Last Decade

Ray Hachem

213 papers receiving 8.6k citations

Peers

Countries citing papers authored by Ray Hachem

Since Specialization

Citations

This map shows the geographic impact of Ray Hachem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray Hachem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray Hachem more than expected).

Fields of papers citing papers by Ray Hachem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ray Hachem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray Hachem. The network helps show where Ray Hachem may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ray Hachem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ray Hachem Line = papers co-authored together Ray Hachem links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tocilizumab for Donor Specific Antibodies in Lung Transplantation The Journal of Heart and Lung Transplantation ·Maria Jagodzinska, 眞幸百瀬, Hrishikesh S. Kulkarni, Ray Hachem	2025	0
2	In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer JAC-Antimicrobial Resistance ·Eric Fredricksen, Joel Rosenblatt, 俊典藪中, Ying Jiang, Samuel A. Shelburne, Anne‐Marie Chaftari, Ray Hachem, Issam Raad	2024	6
3	A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia Journal of Antimicrobial Chemotherapy ·Anne‐Marie Chaftari, Odille Mejia‐Mejia, Ray Hachem, Ying Jiang, Luca Lupária, Alessandro Fillac, Teny M. John, D. Baldwin, Elena Butovsky, Julia Perret, Regina Baaijens, Ying Yuan, Patrick Chaftari, Issam Raad	2024	4
4	528. Matched Retrospective Study, Comparing Molnupiravir to Nirmatrelvir-Ritonavir (Paxlovid) in the Treatment of Mild-Moderate COVID-19 in Immunocompromised Cancer Patients Open Forum Infectious Diseases ·Alyaa Adel, Fadil Kastra, Ray Hachem, Ying Jiang, Odille Mejia‐Mejia, Patrick Chaftari, Anne‐Marie Chaftari, Issam Raad	2023	0
5	364. Novel Polygalacturonic and Caprylic Acid (PG+CAP) Antimicrobial Wound Ointment is Effective in Managing Microbially Contaminated Chronic Wounds in a Pilot Prospective Randomized Clinical Study Open Forum Infectious Diseases ·Ray Hachem, Yanbing Chen, Odille Mejia‐Mejia, Bastian Bastian, Sabrina Clara Martorelli Ribeiro, Nelson Hamerschlak, Lawan Adamu, Joel Rosenblatt, Ying Jiang, Anne‐Marie Chaftari, فاكية فتح الله, Amir Ibrahim, Abdul Rahman Bizri, Issam Raad	2023	2
6	In vitro activity of tebipenem and comparator agents against bacterial pathogens isolated from patients with cancer JAC-Antimicrobial Resistance ·Eric Fredricksen, Joel Rosenblatt, 기동진, Anne‐Marie Chaftari, Ray Hachem, Issam Raad	2023	4
7	A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies Open Forum Infectious Diseases ·Anne‐Marie Chaftari, Ray Hachem, Alexandre Malek, Victor E. Mulanovich, Ariel D. Szvalb, Ying Jiang, Ying Yuan, Jing-Long Hong, Klunko Natalia S., Patrick Chaftari, Issam Raad	2022	9
8	Management of enterococcal central line-associated bloodstream infections in patients with cancer BMC Infectious Diseases ·رياض عزيز عباس, Anne‐Marie Chaftari, 平野章, H. Seitz, Ying Jiang, Klunko Natalia S., Jing-Long Hong, Ray Hachem, Issam Raad	2021	12
9	Pro-adrenomedullin as a Novel Biomarker for Predicting Infections and Response to Antimicrobials in Febrile Patients With Hematologic Malignancies Clinical Infectious Diseases ·Saïd Daoud, Seren ÇATALTEPE, Anne‐Marie Chaftari, Antonella Nardi, William Shomali, Ying Jiang, Labib Debiane, Sean Cottrell, Sam Campbell, 武久壁谷, Ray Hachem, Issam Raad	2013	53
10	Outcome Analysis of Invasive Aspergillosis in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients: The Role of Novel Antimold Azoles The Oncologist ·Elizabeth Ramos, Ying Jiang, Ray Hachem, Christelle Kassis, Dimitrios P. Kontoyiannis, Issam Raad	2011	43
11	Drug-Induced Nephrotoxicity Caused by Amphotericin B Lipid Complex and Liposomal Amphotericin B Medicine ·Amar Safdar, Jonathan Ma, Pedro Fito-Maupoey, B. Dupont, John R. Wingard, Ray Hachem, Gloria Mattiuzzi, Pranatharthi Chandrasekar, Dimitrios P. Kontoyiannis, Kenneth V. I. Rolston, Thomas J. Walsh, Richard E. Champlin, Issam Raad	2010	73
12	Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort European Journal of Clinical Microbiology & Infectious Diseases ·J. Hiemenz, Issam Raad, J. Maertens, Ray Hachem, Alfred J. Saah, Carole A. Sable, J Chodakewitz, Doris Jo Black, Patricia Saddier, Russell S. Berman, Desmon̄d Ryan, Mark J. DiNubile, Thomas F. Patterson, David W. Denning, Thomas J. Walsh	2010	32
13	Novel Antiseptic Urinary Catheters for Prevention of Urinary Tract Infections: Correlation of In Vivo and In Vitro Test Results Antimicrobial Agents and Chemotherapy ·Ray Hachem, Ruth Reitzel, Agatha Borne, Ying Jiang, Peggy T. Tinkey, Rajesh Uthamanthil, Jyotsna Chandra, Mahmoud A. Ghannoum, Issam Raad	2009	69
14	Risk of Bioaerosol Contamination With Aspergillus Species Before and After Cleaning in Rooms Filtered With High-Efficiency Particulate Air Filters That House Patients With Hematologic Malignancy Infection Control and Hospital Epidemiology ·Gandarvaka L. Gray, Maria Teresa Santos, Ying Jiang, Brenda Hackett, Ray Hachem, Roy F. Chemaly, Issam Raad	2007	20
15	Fungal Sinusitis in the Immunocompetent Patient: Risk Factors and Surgical Management Surgical Infections ·Usamah Hadi, Ray Hachem, Kwang Ho, Rola Husni, Issam Raad	2003	1
16	The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer The American Journal of Medicine ·Gerald P. Bodey, Masoud Mardani, Hend Hanna, Maha Boktour, Jalal Abbas, Essam Girgawy, Ray Hachem, Dimitrios P. Kontoyiannis, Issam Raad	2002	163
17	Treatment of Nosocomial Postoperative Pneumonia in Cancer Patients: A Prospective Randomized Study Annals of Surgical Oncology ·Issam Raad, Ray Hachem, Hend Hanna, Dima Abi-Said, Carol Bivins, G. Walsh, U. Leiste, Estella Whimbey, Armando Huaringa, Sukumaran Anil	2001	6
18	Comparison of Two Antimicrobial—Impregnated Central Venous Catheters Survey of Anesthesiology ·Rabih O. Darouiche, Issam Raad, Stephen O. Heard, John I. Thornby, Olivier C. Wenker, Andrea Gabrielli, Johannes Berg, N.M. Khardori, Hend Hanna, Ray Hachem, Richard L. Harris, Glen Mayhall	1999	20
19	A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients Cancer ·Issam Raad, Estella Whimbey, Kenneth Rolston, Dima Abi-Said, Ray Hachem, P. G. Scholer, Habib M. Ghaddar, Hiromi Sakamoto, Gerald P. Bodey	1996	37
20	A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients Cancer ·Issam Raad, Estella Whimbey, Kenneth V. I. Rolston, Marissa Pretell, Ray Hachem, P. G. Scholer, Habib M. Ghaddar, Hiromi Sakamoto, Gerald P. Bodey	1996	3

About Ray Hachem

Ray Hachem is a scholar working on Emergency Medical Services, Clinical Biochemistry, Infectious Diseases, Epidemiology and Small Animals, having authored 218 papers that have together received 8.9k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (65 papers), Central Venous Catheters and Hemodialysis (62 papers), Fungal Infections and Studies (55 papers), Neutropenia and Cancer Infections (48 papers), Bacterial Identification and Susceptibility Testing (45 papers), Antimicrobial Resistance in Staphylococcus (35 papers), Infective Endocarditis Diagnosis and Management (29 papers) and Antibiotics Pharmacokinetics and Efficacy (24 papers). The work is most often cited by research in Infectious Diseases (4.9k citations), Emergency Medical Services (1.4k citations), Applied Microbiology and Biotechnology (331 citations), Clinical Biochemistry (1.1k citations) and Epidemiology (4.5k citations). Ray Hachem has collaborated with scholars based in United States, Lebanon and Japan. Frequent co-authors include Issam Raad, Hend Hanna, Dimitrios P. Kontoyiannis, Ying Jiang, Gerald P. Bodey, Maha Boktour, Tanya Dvorak, Roy F. Chemaly, Anne‐Marie Chaftari and Ruth Reitzel. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Cancer, Open Forum Infectious Diseases, Clinical Infectious Diseases and Infection Control and Hospital Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact